Nuclear Radiology: Page 48

Perma-Fix subsidiary partners with Digirad for Tc-99m deal
By AuntMinnieEurope.com staff writers
Perma-Fix Environmental Services announced that its Polish subsidiary, Perma-Fix Medical, has finalized its partnership with nuclear medicine firm Digirad regarding technetium-99m (Tc-99m).
July 26, 2015
Blue Earth secures $28M in venture capital
By AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.
July 22, 2015
Blue Earth gets orphan drug status
By AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has received two orphan drug designations for its F-18 fluciclovine radiopharmaceutical for diagnosing glioma.
July 7, 2015
Global isotope market could reach $7B by 2020
By AuntMinnieEurope.com staff writers
Widespread use of radiopharmaceutical isotopes with diagnostic equipment such as PET and SPECT systems could buoy the global nuclear medicine/radiopharmaceutical market to $7 billion by the end of the decade.
July 7, 2015
AAA signs Fuji as distributor in Japan
By AuntMinnieEurope.com staff writers
French molecular imaging firm Advanced Accelerator Applications (AAA) has signed a distribution deal for its Lutathera radiopharmaceutical with Fujifilm RI Pharma in Japan.
June 30, 2015
AAA nets $29M for new products
By AuntMinnieEurope.com staff writers
French molecular imaging firm Advanced Accelerator Applications (AAA) has garnered $28.7 million (23 million euros) in financing from U.S.-based investors.
June 24, 2015
Florbetaben-PET finds more beta-amyloid plaques
By Wayne Forrest
New research indicates that PET imaging with the radiotracer florbetaben can detect a form of beta-amyloid plaque that develops early in the brain. The findings could possibly lead to the earlier detection of Alzheimer's disease, as well as new clinical indications for florbetaben.
June 24, 2015
2015 06 18 11 46 01 878 Catafau Florbetaben 200
CT of chest pain; showing patients their calcified arteries; update on PACS monitors
By Philip Ward
June 16, 2015
SNMMI: FDG-PET/CT predicts ovarian cancer survival
By Wayne Forrest
BALTIMORE - FDG-PET/CT scans can help predict disease progression and overall survival of ovarian cancer patients for as long as several years after treatment, according to a German presentation made on 9 June at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 10, 2015
2015 06 10 11 23 36 617 Baltimore Harbor 200
SNMMI: Germans scoop Image of the Year award
By Wayne Forrest
BALTIMORE - German research using a PET radiotracer for prostate cancer that can be labeled with different radioisotopes for diagnostic or therapeutic use won the Image of the Year prize at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 8, 2015
2015 06 10 09 26 49 636 Snmmi Image Of The Year 200
SNMMI: PET prostate image lands Image of the Year honors
By Wayne Forrest
BALTIMORE - A PET radiotracer for prostate cancer that can be labeled with different radioisotopes for both diagnostic and therapeutic use won Image of the Year honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 8, 2015
2015 06 08 11 32 07 124 Snmmi Image Of The Year 200
SNMMI: Amyloid scintigraphy predicts major cardiac events
By AuntMinnieEurope.com staff writers
A new scintigraphy molecular imaging scan can pinpoint the dangerous buildup of amyloid proteins in the heart and predict major adverse cardiac events, according to a study presented this week at the Society of Nuclear Medicine and Molecular Imaging conference in Baltimore.
June 7, 2015
Previous Page
Page 48 of 90
Next Page